Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today noted that our partner, Akeso, Inc. ("Akeso, ...